TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants March 13, 1981